Overview

Update
Status
Adnavance Technologies has been closed
Total Equity Funding
$7.59M in 2 Rounds from 5 Investors
Headquarters:
San Diego, CA
Description:
Adnavance Technologies develops direct detection molecular diagnostic tests for medical applications.
Categories:
Biotechnology
Website:
http://www.adnavance.com

Company Details

Update

Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.

Funding Rounds (2) - $7.59M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2008$3.7M / Series B3
Nov, 2005$3.85M / Series A3

News (2)

Update

Offices/Locations (1)

Update
  • Office

    11494 Sorrento Valley Road, Suite H

    San Diego, CA 92121

    USA

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos